Company · PFE
Pfizer
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
423
168 still marketed
Novel approvals
130
Approvals since 2021
62
Originals and new uses
Phase 3 trials
815
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Talzenna new use Priority reviewOct 26, 2026
- Talzenna new use Priority reviewOct 26, 2026
- Tukysa new use OrphanOct 7, 2026
- Ibrance new use Breakthrough therapyJun 24, 2026
- Ibrance new use Breakthrough therapyJun 24, 2026
- Hympavzi new use Priority reviewOrphanJun 5, 2026
- Xeljanz new use Mar 6, 2026
- Xeljanz Xr new use Mar 6, 2026
- Xeljanz new use Oct 16, 2025
- Ibrance new use Sep 16, 2025
Drugs in development (38)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
- BerobenatidePF-08653944, MET097Phase 319 trials
Pfizer · Obesity, Overweight and/or Obesity, Overweight
- GiredestrantRO7197597, GDC-9545Phase 316 trials
Roche (Genentech) · Early Breast Cancer, Breast Cancer, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
- PF-08634404SSGJ-707Phase 312 trials
Pfizer · Non-Small Cell Lung Cancer, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung (NSCLC)
- AtirmociclibPF-07220060Phase 39 trials
Pfizer · Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer
- PF-07275315tilrekimigPhase 38 trials
Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease
- RSVpreFRESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE, PF-06928316Phase 38 trials
Pfizer · Respiratory Syncytial Virus (RSV), Lower Respiratory Tract Illness, Adult
- PG4Phase 35 trials
Pfizer · Pneumococcal Disease
- DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials
Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization
- VLA15PF-07307405Phase 34 trials
Pfizer · Lyme Disease, Lyme Borreliosis
- CasdatifanAB521Phase 33 trials
Arcus Biosciences, Inc. · Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma (RCC)
- Leuprorelin acetateLeuprolide Open Label, DKF-MA102Phase 33 trials
Pfizer · Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
- MevrometostatPF-06821497Phase 33 trials
Pfizer · Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer
- RSVpreF VaccinePhase 33 trials
Pfizer · Respiratory Syncytial Virus, Respiratory Syncytial Virus (RSV)
- Sigvotatug VedotinSGN-B6A, PF-08046047Phase 33 trials
Pfizer · Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
- C.difficile vaccinepreviously studiedPhase 32 trials
Pfizer · Clostridoides Difficile Associated Disease
- CMP 001VidutolimodPhase 32 trials
Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer
- ibuzatrelvirPF-07817883Phase 32 trials
Pfizer · COVID-19 SARS-CoV-2 Infection, COVID-19 Infection
- PF-07248144Phase 32 trials
Pfizer · Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
- PF-08046054SGN-PDL1VPhase 32 trials
Pfizer · Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma
- su vaccineRZVPhase 32 trials
GSK · Herpes Zoster, Respiratory Syncytial Virus (RSV)
- PF-06823859Phase 31 trial
Pfizer · Myositis
- PF-06838435fidanacogene elaparvovecPhase 31 trial
Pfizer · Hemophilia B
- PF04518600Phase 31 trial
Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer
- ponsegromabPhase 31 trial
Pfizer · Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
- Prevenar 20Phase 31 trial
Pfizer · Healthy
Recruiting Phase 3 trials
Largest first.
- A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderPivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT07282665 · 32,500 participants (planned) · Start Dec 10, 2025 · Primary completion Dec 11, 2028
Drug: C.difficile vaccine · For: Clostridoides Difficile Associated Disease
Sites: Athens, Alabama; Guntersville, Alabama; Huntsville, Alabama · 185 sites in all
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their BabiesPivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT07160244 · 6,000 participants (planned) · Start Aug 25, 2025 · Primary completion Nov 6, 2028
Drug: Multivalent Group B streptococcus vaccine; Placebo and 5 more · For: Healthy
Sites: Birmingham, Alabama; Dothan, Alabama; Mobile, Alabama · 219 sites in all
- A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.Pivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT07629440 · 3,230 participants (planned) · Start May 29, 2026 · Primary completion Jun 5, 2029
Drug: PG4; 20-valent pneumococcal conjugate vaccine (20vPnC) · For: Pneumococcal Disease
Sites: Birmingham, Alabama; Fayetteville, Arkansas; Jonesboro, Arkansas · 134 sites in all
- A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy InfantsPivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT07573462 · 2,400 participants (planned) · Start May 4, 2026 · Primary completion Dec 30, 2028
Drug: PG4; 20-valent pneumococcal conjugate vaccine (20vPnC) · For: Pneumococcal Disease
Sites: Estero, Florida; Fort Lauderdale, Florida; Fort Myers, Florida · 91 sites in all
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseasePivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT06679140 · 2,330 participants (planned) · Start Dec 8, 2024 · Primary completion Oct 1, 2027
Drug: ibuzatrelvir; placebo · For: COVID-19 SARS-CoV-2 Infection
Sites: Huntsville, Alabama; Little Rock, Arkansas; Bakersfield, California · 256 sites in all
- Randomized Study in Children and Adolescents With Migraine: Acute TreatmentPivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT04649242 · 2,100 participants (planned) · Start Jan 15, 2021 · Primary completion Jan 9, 2029
Drug: Rimegepant/BHV3000; Matching placebo · For: Pediatric Migraine
Sites: Birmingham, Alabama; Scottsdale, Arizona; Tempe, Arizona · 246 sites in all
- A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease VaccinePivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT07500506 · 1,712 participants (planned) · Start Apr 8, 2026 · Primary completion Dec 4, 2026
Drug: VLA15; Placebo · For: Lyme Disease
Sites: Bangor, Maine; Worcester, Massachusetts; Flemington, New Jersey · 22 sites in all
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerPivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT07222566 · 1,410 participants (planned) · Start Jan 6, 2026 · Primary completion Feb 27, 2029
Drug: PF-08634404; Pembrolizumab and 2 more · For: Advanced Non-Small Cell Lung Cancer; Non-Small Cell Lung Cancer; Carcinoma, Non-Small-Cell Lung and 3 more
Sites: Bullhead City, Arizona; Chandler, Arizona; Gilbert, Arizona · 484 sites in all
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaPivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT07783425 · 1,375 participants (planned) · Start Aug 24, 2026 · Primary completion Sep 8, 2028
Drug: Tilrekimig; Dupilumab · For: Atopic Dermatitis
Sites: Birmingham, Alabama; Phoenix, Arizona; Bryant, Arkansas · 50 sites in all
PfizerPfizer (PFE)
NCT07839884 · 1,360 participants (planned) · Start Oct 14, 2026 · Primary completion Apr 21, 2034
Drug: Tilrekimig · For: Moderate to Severe Chronic Obstructive Pulmonary Disease
Sites: San Diego, California; Winston-Salem, North Carolina; DuBois, Pennsylvania
Marketed drugs (168)
Newest FDA action first.
- Hympavzi Marstacimab-Hncq · 2024
- Talzenna Talazoparib Tosylate · 2024
- Zyvox Linezolid · 2000
- Zyvox Linezolid · 2000
- Methotrexate Preservative Free Methotrexate Sodium · 1959
- Azulfidine En-Tabs Sulfasalazine · 1950
- Tukysa Tucatinib · 2020
- Ruxience Rituximab-Pvvr · 2019
- Xeljanz Tofacitinib Citrate · 2020
- Xeljanz Xr Tofacitinib Citrate · 2016
- Cibinqo Abrocitinib · 2022
- Cleocin Hydrochloride Clindamycin Hydrochloride · 1970
- Zavzpret Zavegepant Hydrochloride · 2023
- Zithromax Azithromycin · 2002
- Zithromax Azithromycin · 1995
- Zithromax Azithromycin · 1996
- Litfulo Ritlecitinib Tosylate · 2023
- Ibrance Palbociclib · 2015
- Ibrance Palbociclib · 2019
- Linezolid In Sodium Chloride 0.9% In Plastic Container Linezolid · 2015
- Nyvepria Pegfilgrastim-Apgf · 2020
- Nurtec Odt Rimegepant Sulfate · 2020
- Precedex Dexmedetomidine Hydrochloride · 1999
- Ngenla Somatrogon-Ghla · 2023
- Cleocin Phosphate Clindamycin Phosphate · 1972
- Elrexfio Elranatamab · 2023
- Estring Estradiol · 1996
- Paxlovid (Copackaged) Nirmatrelvir, Ritonavir · 2023
- Idarubicin Hydrochloride Idarubicin Hydrochloride · 1997
- Lorbrena Lorlatinib · 2018
- Morphine Sulfate Morphine Sulfate · 2011
- Hydromorphone Hydrochloride Hydromorphone Hydrochloride · 2011
- Prostin Vr Pediatric Alprostadil · 1981
- Elelyso Taliglucerase Alfa · 2012
- Fentanyl Citrate Fentanyl Citrate · 1985
- Demerol Meperidine Hydrochloride · 1942
- Abrilada Adalimumab-Afzb · 2019
- Depo-Subq Provera 104 Medroxyprogesterone Acetate · 2004
- Depo-Provera Medroxyprogesterone Acetate · 1992
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container Dobutamine Hydrochloride · 1993
- Synarel Nafarelin Acetate · 1990
- Heparin Sodium 25,000 Units In Sodium Chloride 0.9% In Plastic Container Heparin Sodium · 1984
- Aldactazide Hydrochlorothiazide, Spironolactone · 1961
- Aldactone Spironolactone · 1960
- Cleocin T Clindamycin Phosphate · 1989
- Cleocin T Clindamycin Phosphate · 1987
- Tivdak Tisotumab Vedotin-Tftv · 2021
- Unasyn Ampicillin Sodium, Sulbactam Sodium · 1986
- Medrol Methylprednisolone · 1957
- Depo-Medrol Methylprednisolone Acetate · 1959
- Solu-Medrol Methylprednisolone Sodium Succinate · 1959
- Nipent Pentostatin · 1991
- Ixifi Infliximab-Qbtx · 2017
- Heparin Sodium Heparin Sodium · 2011
- Cyklokapron Tranexamic Acid · 1986
- Trazimera Trastuzumab-Qyyp · 2019
- Velsipity Etrasimod Arginine · 2023
- Atropine Sulfate Atropine Sulfate · 2001
- Dextrose 50% Dextrose · 1986
- Cupric Chloride In Plastic Container Cupric Chloride · 1986
- Genotropin Preservative Free Somatropin · 1995
- Dextrose 5% In Plastic Container Dextrose · 1985
- Dextrose 5% In Plastic Container Dextrose · 1985
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container Dopamine Hydrochloride · 1983
- Daptomycin Daptomycin · 2021
- Premarin Estrogens, Conjugated · 1978
- Premarin Estrogens, Conjugated · 1942
- Prempro Estrogens, Conjugated, Medroxyprogesterone Acetate · 1995
- Metronidazole In Plastic Container Metronidazole · 1983
- Aromasin Exemestane · 1999
- Ellence Epirubicin Hydrochloride · 1999
- Arthrotec Diclofenac Sodium, Misoprostol · 1997
- Feldene Piroxicam · 1982
- Mycobutin Rifabutin · 1992
- Caduet Amlodipine Besylate, Atorvastatin Calcium · 2004
- Fragmin Dalteparin Sodium · 1994
- Furosemide Furosemide · 1982
- Zirabev Bevacizumab-Bvzr · 2019
- Protonix Iv Pantoprazole Sodium · 2001
- Solu-Cortef Hydrocortisone Sodium Succinate · 1955
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.